Change at centre of NHS plan
April 12, 2013Sales and Marketing Mid Staffs, NHS, putting patients first
The shadow of Mid Staffs looms long over NHS England’s new three-year business plan, with a move towards fundamental change …
Roche signs Huntington’s deal
April 10, 2013Research and Development, Sales and Marketing Huntington's, Isis, Roche
Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …
Bristol-Myers Squibb appoints executive as another retires
April 10, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS
Bristol-Myers Squibb has announced the appointment of Francis Cuss as executive VP and chief scientific officer following Elliott Sigal’s intentions …
MedImmune buys AlphaCore
April 9, 2013Research and Development AlphaCore, AstraZeneca, MedImmune
AstraZeneca’s biologics R&D arm MedImmune has bought private US biotech firm AlphaCore Pharma for an undisclosed sum.The acquisition is part …
Pharma pays doctors £40m
April 9, 2013Sales and Marketing ABPI, Bad pharma, ethics
Health professionals received £40 million in payments from pharma companies last year, according to new figures released by the ABPI.This …
New head at European Medicines Agency
April 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA
The European Medicines Agency has appointed Agneta Brandt as the new head of Infrastructure Services. Brandt joins the Agency from …
Ten pharma firms censured
March 28, 2013Medical Communications, Sales and Marketing ABPI, PMCPA
Ten pharma companies have been found guilty by the PMCPA of failing to maintain high standards over their involvement in …
US nod for Tecfidera
March 28, 2013Sales and Marketing Biogen, FDA, tecfidera
The FDA has given Biogen Idec’s oral multiple sclerosis treatment Tecfidera the green light. Earlier this week Tecfidera (dimethyl fumarate) …
Star commercial academy appoints director
March 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Star
Gary Lunt has been appointed to the newly created role of Business Development director with training agency STAR Commercial Academy. …
New ‘culture of compassion’ for NHS
March 27, 2013Sales and Marketing Francis, Francis report, Hunt, Mid Staffs, NHS, Staffs
The government has launched plans to ensure that the needs of patients are paramount in any future dealings with the …
FDA delays GSK flu vaccine
March 27, 2013Research and Development, Sales and Marketing FDA, GSK, Vaccine
The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …
Multiple sclerosis rivals gain EU approval
March 27, 2013Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS
Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …
Chiltern announces two promotions
March 26, 2013Manufacturing and Production, Research and Development, Sales and Marketing chiltern
Global clinical contract research organisation Chiltern International has announced the promotions of Stuart McGuire and Jim Szymeczek.“I am pleased to …
AstraZeneca settles Crestor case
March 26, 2013Sales and Marketing AstraZeneca, Crestor, Watson
AstraZeneca has settled a long-running legal battle over one of its biggest brands, Crestor, whose patent expires in 2016. The …
Sanofi in immunotherapy tie-up
March 26, 2013Research and Development, Sales and Marketing Transgene, snaofi
Sanofi has signed a 15-year deal with biopharma company Transgene to produce a platform to help create a range of …
Africa rising
March 26, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Lunt
Africa has been a byword for poverty, disease and political turmoil for generations, and many people in the most developed …
New chief executive for Eyevensys
March 26, 2013Manufacturing and Production, Research and Development, Sales and Marketing Eyevensys
Gene therapy development firm Eyevensys has announced the appointment of Dr Ivan Cohen-Tanugi as chief executive.Cohen-Tanugi has over 20 years’ …
Xarelto gets EU nod
March 25, 2013Sales and Marketing Bayer, Xarelto
Bayer HealthCare has been given a boost by the recommendation in Europe of its oral blood thinner Xarelto to prevent …
LEO Pharma appoints two divisional directors
March 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma
LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …
AstraZeneca hires strategy boss
March 25, 2013Sales and Marketing AstraZeneca, dunoyer
AstraZeneca has poached one of GlaxoSmithKline’s senior executives to help push through its new growth strategy. Marc Dunoyer, global head …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
